FLCN and follicular lymphoma: Studies have shown that RRAGC-activating mutations are found in approximately 10% of follicular lymphomas, with the mutated RRAGC protein showing increased binding to RPTOR (raptor) and significantly reduced interaction with the product of the tumor suppressor gene FLCN (follicle protein).